Health care

Error message

Deprecated function: The each() function is deprecated. This message will be suppressed on further calls in _menu_load_objects() (line 579 of /var/www/drupal-7.x/includes/menu.inc).

The Campaign to Protect Christmas Profits from Omicron

Published by Anonymous (not verified) on Mon, 29/11/2021 - 10:03pm in

Omicron updates along with some of the considerable noise.

Ohio Jury Finds Three Pharmacy Chains Liable in Opioids Trial; Judge to Decide on Damages Award in Spring

This is the first opioids jury verdict yet handed down; thousands of opioids cases remain pending.

Probable Vaccine-Escaping Covid Variant Sequenced in Gauteng, South Africa and Spreading Rapidly; Press Underplaying Downside Risk

Published by Anonymous (not verified) on Fri, 26/11/2021 - 8:52pm in

A very nasty new variant is spreading rapidly and looks to evade monoclonal antibodies and current vaccines. Assume the brace position.

How the Pandemic Helped Spread Fentanyl Across the US and Drive Opioid Overdose Deaths to a Grim New High

Published by Anonymous (not verified) on Thu, 25/11/2021 - 1:55am in

The jump in opioid deaths during the pandemic was due significantly to distribution changes that favored fentanyl.

Go Private for the Treatment You Need, NHS Tells Patients

NHS patients are being refused treatment, discharged too early and pushed towards private referrals.

Austria Imposes Full Covid Lockdown and Plans Mandatory Vaccination Early Next Year

Published by Anonymous (not verified) on Fri, 19/11/2021 - 10:51pm in

Austria is the first country to go full lockdown after the introduction of the Covid vaccines...and at a higher vaccination rate than the US.

New, Radically Different Covid Variant Getting Footholds Now as Media and Officials Remain Complacent

Published by Anonymous (not verified) on Fri, 19/11/2021 - 10:16pm in

A very different Covid variant has made its way out of Africa into Europe and the US. How worried should you be?

Pharma Dems Saved The Drug Industry Half A Trillion Dollars

Published by Anonymous (not verified) on Thu, 18/11/2021 - 2:53am in

Click to share this on FacebookPharma Dems Saved The Drug Industry Half A Trillion Dollars

Big Pharma’s massive lobbying campaign and advertising offensive against Democrats’ drug pricing plan saved the industry nearly half a trillion dollars. That represents a return of more than 1,700 times the investment the drug industry has made on lobbying Congress this year.

This outcome illustrates why industry groups are willing to throw ungodly sums of money at influencing Washington lawmakers. While spending hundreds of millions on lobbying and advocacy efforts might seem exorbitant, it’s nothing compared to the hundreds of billions these business interests stand to lose if legislative decisions don’t go their way.

Tip Jar

In September, House Democrats estimated that the drug pricing provisions in their Build Back Better agenda reconciliation bill would save $700 billion over a decade. Democrats’ compromise drug plan — negotiated by pharmaceutical industry favorites Sen. Kyrsten Sinema of Arizona, Rep. Scott Peters of California, and Rep. Kurt Schrader of Oregon — would only save $250 billion during that same time, according to the Committee for a Responsible Federal Budget, a pro-austerity think tank. The difference equals $450 billion in savings.

According to data from OpenSecrets, the pharmaceutical and health products industries have spent $263 million on lobbying in Washington so far this year. Dark money groups with ties to Big Pharma have run misleading ad campaigns promoting the Democrats who worked to gut the party’s drug pricing measure, and they have also spent millions on ads attacking the entire concept of allowing the government to negotiate drug prices — an idea that is broadly popular and one that many other countries have implemented.

In a new tax return obtained by The Daily Poster, Pharmaceutical Research and Manufacturers of America (PhRMA) disclosed donating another $2.7 million in 2020 to Center Forward, a dark money group that’s spent at least $1.2 million touting Sinema in Arizona in recent months. PhRMA, a powerful drug lobbying group, contributed $7.2 million to Center Forward from 2016-20, accounting for more than a quarter of its revenue. PhRMA brought in $573 million in revenue last year.

The lobbying and related advocacy blitz by Big Pharma to boost allied lawmakers and oppose Democrats’ drug pricing measure may seem staggering, especially if you live in a state or district flooded with their ads. But in total, the effort will end up costing less than 0.1 percent of the $450 billion the industry will get to keep thanks to corporate Democrats’ handiwork. And drug lobbyists are still working to chip away at the legislation further and block provisions that would limit future price hikes.

Give a Gift Subscription

Of course, there is some chance that Democrats won’t manage to pass their Build Back Better bill at all, despite negotiating the legislation since March. But if the bill does become law, voters may not even begin to see any savings from the drug pricing provisions until after the 2022 midterm elections, when Democrats could lose control of Congress — and some other changes wouldn’t take effect until after the 2024 presidential election.

As Politico noted on Monday, “Penalties on drugmakers that hike prices faster than inflation and a new $35-per-month cap on insulin won’t begin until 2023. A $2,000 cap for all out-of-pocket drug spending for seniors won’t be implemented until 2024, and the lower prices Medicare will negotiate with pharmaceutical companies for some of the most expensive drugs won’t be available until 2025 — with a full phase-in coming in 2028.”

This newsletter relies on readers pitching in to support our journalism. If you like this story, please support The Daily Poster's work.

As Big Pharma and Hospitals Battle Over Drug Discounts, Patients Miss Out on Millions in Benefits

Published by Anonymous (not verified) on Tue, 16/11/2021 - 10:10pm in

Another ugly feature of drug company grifting: fighting to deny discounts to hospital pharmacies, as required by law.

Nurses Don’t Want to Be Hailed as ‘Heroes’ During a Pandemic – They Want More Resources and Support

Published by Anonymous (not verified) on Sun, 14/11/2021 - 9:55pm in

The public and health care organizations can help nurses now by increasing access to mental health support and providing adequate resources, safe working conditions and organizational transparency.

Pages